5-hydroxymethylcytosine has been researched along with Adenocarcinoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, EG; Chang, MY; Cheng, Y; Jin, MH; Jin, P; Liu, H; Shu, Q; Wang, X; Xu, T | 1 |
| Cao, F; Guo, Z; He, Y; Hu, X; Li, A; Liu, H; Tu, K; Wei, A; Xia, L; Xie, D; Yuan, J; Zhang, J | 1 |
| Lai, M; Tian, Y; Zhang, H; Zhong, A | 1 |
| Akazawa, Y; Hayashi, T; Murakami, T; Nagahara, A; Saito, T; Tsuyama, S; Ueyama, H; Watanabe, S; Yanai, Y; Yao, T; Yatagai, N | 1 |
| Bissonnette, MB; Butun, F; Chapman, CG; Chuang, A; Godley, LA; Kwon, JH; Madzo, J; Mariani, CJ; Meckel, K; Wu, F | 1 |
| Argani, P; Chaux, A; De Marzo, AM; Esopi, DM; Gerber, J; Haffner, MC; Iacobuzio-Donahue, C; Meeker, AK; Nelson, WG; Netto, GJ; Pellakuru, LG; Toubaji, A; Yegnasubramanian, S | 1 |
6 other study(ies) available for 5-hydroxymethylcytosine and Adenocarcinoma
| Article | Year |
|---|---|
Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
Topics: 5-Methylcytosine; Adenocarcinoma; Case-Control Studies; DNA Methylation; Epigenesis, Genetic; Genome, Human; Humans; Stomach Neoplasms | 2019 |
Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer.
Topics: 5-Methylcytosine; Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Pancreatic Ductal; Cell-Free Nucleic Acids; Epigenesis, Genetic; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2020 |
DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
Topics: 5-Methylcytosine; Adenocarcinoma; Adenocarcinoma, Mucinous; Biomarkers, Tumor; Colorectal Neoplasms; DNA Methylation; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; Survival Rate | 2018 |
TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation.
Topics: 5-Methylcytosine; Adenocarcinoma; Aged; Aged, 80 and over; Ataxia Telangiectasia Mutated Proteins; Biomarkers, Tumor; Cell Differentiation; DNA Methylation; Female; Gene Silencing; Humans; Loss of Heterozygosity; Lymphatic Metastasis; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Neoplasm Staging; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stomach Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53 | 2019 |
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer.
Topics: 5-Methylcytosine; Adenocarcinoma; Binding Sites; Cell Differentiation; Cell Line, Tumor; Colon; Colonic Neoplasms; Cytosine; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Mixed Function Oxygenases; Proto-Oncogene Proteins; Transcription Factors | 2015 |
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers.
Topics: 5-Methylcytosine; Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Differentiation; Colonic Neoplasms; Cytosine; Down-Regulation; Embryo, Mammalian; Female; Gestational Age; HEK293 Cells; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Prostatic Neoplasms; Stem Cells | 2011 |